| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/17/2008 | WO2008086086A2 Glucagon analogs exhibiting enhanced solubility in physiological ph buffers |
| 07/17/2008 | WO2008085563A1 Recombinant viral proteins and particles |
| 07/17/2008 | WO2008085543A2 Multimeric elp fusion constructs |
| 07/17/2008 | WO2008085502A2 A green fluorescent protein optimized for expression with self-cleaving polypeptides |
| 07/17/2008 | WO2008085494A1 Short bio-active peptides for cellular and immunological modulation |
| 07/17/2008 | WO2008085406A2 Modified live (jmso strain) haemophilus parasuis vaccine |
| 07/17/2008 | WO2008084710A1 Inhibitor of herpesvirus infection, method for inhibition of herpesvirus infection, and use thereof |
| 07/17/2008 | WO2008084478A2 Anti-bacterial peptides and methods of treating diseases using same |
| 07/17/2008 | WO2008084115A2 Lactococcus promoters and uses thereof |
| 07/17/2008 | WO2008084069A1 A method for expanding monocytes |
| 07/17/2008 | WO2008083976A1 Proteolytic cleavage of protein tags in recombinant protein production |
| 07/17/2008 | WO2008083841A1 Use of synthetically produced spider silk |
| 07/17/2008 | WO2008083615A1 Complexes comprising angiostatin and its fragments, preparation preparing methods and uses thereof |
| 07/17/2008 | WO2008083598A1 Transgenic crop being selectively killed, preparation and utilization thereof |
| 07/17/2008 | WO2008083441A1 Boron transporter |
| 07/17/2008 | WO2008055916A3 New antigens for paratuberculosis diagnosis and vaccination |
| 07/17/2008 | WO2008028601A3 Method for improving the specific effector function of single-chain antigen-recognizing genetic constructs (scarc) through murinization thereof |
| 07/17/2008 | WO2008024767A3 Method and composition for treating a fibrotic disorder |
| 07/17/2008 | WO2007149657A3 Antifungal polypeptides |
| 07/17/2008 | WO2007145760A3 Anthrax compositions and methods of use and production |
| 07/17/2008 | WO2007144198B1 Fplr-1 inhibitors for use in diseases involving amyloid-induced inflammatory events (flipr and flipr-like) and immunecomplex-mediated diseases |
| 07/17/2008 | WO2007139941A3 Composition and methods for treatment of congestive heart failure |
| 07/17/2008 | WO2007130655A3 Phage derived antimicrobial activities |
| 07/17/2008 | WO2007115571A3 Erbb receptor-derived peptide fragments |
| 07/17/2008 | US20080172764 Axmi-004, a delta-endotoxin gene and methods for its use |
| 07/17/2008 | US20080172760 Cytokinin Oxidase Promoter from Maize |
| 07/17/2008 | US20080172759 Transgenic plant comprising expression vector coding genes which confer salinity, drought, temperature, metal, chemical and/or pathogenic resistance |
| 07/17/2008 | US20080171855 Polyvalent protein complex |
| 07/17/2008 | US20080171854 Tumor suppressor gene, p47ing3 |
| 07/17/2008 | US20080171853 Formed via solid-state chemistry with 4-methylbenzylhydrylamine functionalized crosslinked polystyrene resin; deblocking, deprotecting; methylation |
| 07/17/2008 | US20080171851 Generation of artificial binding proteins on the basis of ubiquitin proteins |
| 07/17/2008 | US20080171848 Using tris(hydroxymethyl)aminomethane buffering agent in purification of glucagon-like peptides |
| 07/17/2008 | US20080171714 Substances for preventing and treating autoimmune diseases |
| 07/17/2008 | US20080171713 Substances for preventing and treating autoimmune diseases |
| 07/17/2008 | US20080171704 Composition and method for treating diabetes |
| 07/17/2008 | US20080171703 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 07/17/2008 | US20080171702 Novel gene and uses therefor |
| 07/17/2008 | US20080171697 Mitochondriotoxic cyclic polypeptides that induce endocytolysis or angiogenesis in human endothelial cells expressing alpha V beta 3 receptors; anticarcinogenic agents for adenomas, melanomas, osteosarcomas, prostate, breast, colon, or pancreatic cancers; antiarthritici agents; diabetic retinopathy |
| 07/17/2008 | US20080171696 Pharmacodynamically enhanced therapeutic proteins |
| 07/17/2008 | US20080171695 Acylated with polyethylene glycol, polypropylene glycol or polybutylene glycol in combination with a fatty diacid; improved bioavailability, first pass effect, solubility at physiological pH values and prolonged pharmacokinetics |
| 07/17/2008 | US20080171693 Such as Survivn; antiproliferative, antitumor agents; apoptosis; a polypeptide peptidomimetic that includes the amino acid sequence His-Ser-Ser-Gly-Cys |
| 07/17/2008 | US20080171690 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/17/2008 | US20080171689 Having an extracellular domain of an FGFR1 polypeptide having an increased sialaytion level for more stability and a Fc fusion partner; antiproliferative, anticarcinogenic, antitumor agents; angiogenesis inhibitors; |
| 07/17/2008 | US20080171389 Primer sequences for screening and detection of gene sequences in DNA pools |
| 07/17/2008 | US20080171376 Modified bacteriocins and methods for their use |
| 07/17/2008 | US20080171363 Interferon-alpha polypeptides and conjugates |
| 07/17/2008 | US20080171362 Polynucleotides Encoding Proteins with Clot-Specific Streptokinase Activity |
| 07/17/2008 | US20080171358 Expression System |
| 07/17/2008 | US20080171353 Novel guanosine triphosphate-binding protein-coupled receptor place6002312, its gene, and production and uses thereof |
| 07/17/2008 | US20080171349 Alzheimer's Disease Secretase, APP Substrates Therefor and Uses Therefor |
| 07/17/2008 | US20080171348 GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity |
| 07/17/2008 | US20080171345 Biomarkers of tuberculosis that distinguish disease categories: use as serodiagnostic antigens |
| 07/17/2008 | US20080171341 Detection of conformationally altered proteins and prions |
| 07/17/2008 | US20080171339 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 07/17/2008 | US20080171328 Vertebrate hedgehog polypeptide for use as tools in identifying modulators for use in treatment and prevention of nervous system disorders |
| 07/17/2008 | US20080171313 Identifying nucleoside resistant hepatitis b virus based on presence of mutation in polymerase gene |
| 07/17/2008 | US20080171079 Administering an immunogenic composition of Varicella-Zoster Virus gE, or immunogenic fragment, and a TH-1 adjuvant |
| 07/17/2008 | US20080171062 Hepatitis B surface antigen (HBsAg); contain heterologous polyepitopes fused to the middle (M) envelope protein; useful in immunogenic compositions and as vaccines; expression vector for the production of virus-like particles comprising fusion proteins and S proteins of hepatitis B virus (HBV) |
| 07/17/2008 | US20080171060 Lymphocyte receptor peptide for use in prevention and treatment of viral infection, cell proliferative, cardiovascular and allergic disorders; enhancing cytokine production |
| 07/17/2008 | US20080171053 Polypeptides And Immunogenic Conjugates Capable of Inducing Antibodies Against Pathogens, and Uses Thereof |
| 07/17/2008 | US20080171048 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/17/2008 | US20080171046 Novel proteins and nucleic acids encoding same |
| 07/17/2008 | US20080171041 Method for treating inflammation |
| 07/17/2008 | US20080171039 Zinc transporter protein (LIV-1) specific imunoglobulin for use in prevention and treatment of breast cancer |
| 07/17/2008 | US20080171037 Tumor necrosis factor receptor ligand for use in identifying modulators for prevention and treatment of cell proliferative, nervous system, cardiovascular and autoimmune disorders |
| 07/17/2008 | US20080171035 Mammalian cell membrane proteins; related reagents |
| 07/17/2008 | US20080171027 Compositions and Methods for Elimination of Unwanted Cells |
| 07/17/2008 | US20080171026 Using recombinant cells expressing measles virus H glycoprotein to target tumor cells fusion and removal; tissue target therapy |
| 07/17/2008 | US20080171016 Death Domain Containing Receptors |
| 07/17/2008 | US20080171014 Interleukin-13 binding proteins |
| 07/17/2008 | DE4393381B4 PTH-Verbindungen mit PTH-ähnlicher Aktivität, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Zusammensetzungen und deren Verwendungen PTH compounds having PTH-like activity, to processes for their preparation, pharmaceutical compositions containing them and their uses |
| 07/17/2008 | DE102007002580A1 Proteolytische Abspaltung von Protein-Tags in der rekombinanten Protein-Herstellung Proteolytic cleavage of protein tags in recombinant protein production |
| 07/17/2008 | CA2675340A1 Diagnosis and treatment of alzheimer's and other neurodementing diseases |
| 07/17/2008 | CA2675231A1 A conjugate comprising angiostatin or its fragment, the method for producing the conjugate and use thereof |
| 07/17/2008 | CA2675022A1 Adenoviral vector-based malaria vaccines |
| 07/17/2008 | CA2674603A1 Sp35 antibodies and uses thereof |
| 07/17/2008 | CA2674368A1 Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity |
| 07/17/2008 | CA2674354A1 Glucagon analogs exhibiting enhanced solubility in physiological ph buffers |
| 07/17/2008 | CA2673791A1 Cecropin b and hb-107 derived short bio-active peptides for cellular immune modulation |
| 07/17/2008 | CA2663298A1 Alphavirus replicon particles as immunological adjuvants |
| 07/17/2008 | CA2661659A1 Smallpox monoclonal antibody |
| 07/16/2008 | EP1944610A1 Engineering affinity ligands for macromolecules |
| 07/16/2008 | EP1944377A2 Nucleic acid molecules specific for bacterial antigens and uses thereof |
| 07/16/2008 | EP1944374A1 Genes coding for proteins of carbon metabolism and energy production |
| 07/16/2008 | EP1944373A2 Method for purifying interleukin 1 receptor antagonist (IL-1ra) proteins |
| 07/16/2008 | EP1944372A2 Bacillus thuringiensis toxin active against Lepidopteran pests |
| 07/16/2008 | EP1944371A2 Neisseria meningitidis antigens and compositions |
| 07/16/2008 | EP1944370A1 New voltage-dependent potassium channel and its use to develop therapeutic medicine |
| 07/16/2008 | EP1944361A1 A method for expanding monocytes |
| 07/16/2008 | EP1944319A1 T1R Taste Receptors and Genes Encoding Same |
| 07/16/2008 | EP1944318A1 Novel multifunctional cytokines |
| 07/16/2008 | EP1944317A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/16/2008 | EP1944316A1 Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof |
| 07/16/2008 | EP1944315A1 Prophylaxis and therapy of alzheimer's disease and other neurodementing diseases |
| 07/16/2008 | EP1944314A1 Diagnosis of Alzheimer's disease and other neurodementing disorders |
| 07/16/2008 | EP1944313A1 Recombinant malaria vaccine |
| 07/16/2008 | EP1944312A1 Peptides that specifically bind HGF receptor (CMET) and uses thereof |
| 07/16/2008 | EP1944043A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 07/16/2008 | EP1944038A1 Dengue virus capsid protein which induces a protective response and pharmaceutical composition |
| 07/16/2008 | EP1943352A2 Assays for histone deacetylase 1/2 selective inhibitors |